cell 971 words KG: ent-dise-1d66a04d
Contents

APOE4 Homozygous Astrocytes

🧫 Cell Type Info
Cell Typeent-dise-1d66a04d

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (22)

APOE Isoform Expression Across Glial Subtypes
Score: 0.74
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
APOE Isoform Conversion Therapy
Score: 0.72
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
LRP1-Dependent Tau Uptake Disruption
Score: 0.60
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.71
Membrane Cholesterol Gradient Modulators
Score: 0.71
Microbial Inflammasome Priming Prevention
Score: 0.65
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.82
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.75
Senescent Cell Mitochondrial DNA Release
Score: 0.74
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.73
Circadian Rhythm Entrainment of Reactive Astrocytes
Score: 0.72
Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.68
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem
Score: 0.65
pg 1/2Next →

Related Analyses (23)

Neuroinflammation and microglial priming in early AD
neurodegeneration · completed
Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived
How does APOE4's beneficial immune function reconcile with i
neurodegeneration · completed
Which specific metabolic pathways in APOE4+ microglia are mo
neurodegeneration · completed
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived

Related Experiments (25)

Multi-omics analysis of myricanol effects on gene expression
exploratory · proposed · Score: 0.88
APOE4 association with TDP-43 pathology in AD
exploratory · proposed · Score: 0.75
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.45
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40

See Also (15)

LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 8 hypotheses
APOE2 (Apolipoprotein E2)
disease · Pages share 8 hypotheses
remternetug-anti-amyloid-alzheimers
clinical_trial · Pages share 8 hypotheses
APOE3 (Apolipoprotein E3)
disease · Pages share 8 hypotheses
LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy
clinical · Pages share 8 hypotheses

Knowledge Graph (6 edges)

h-var-73142bada1 targets ent-dise-1d66a04d
ent-dise-1d66a04d targeted_by h-var-73142bada1
h-5f98d0e5d4 targets ent-dise-1d66a04d
ent-dise-1d66a04d targeted_by h-5f98d0e5d4
h-16818f9bf1 targets ent-dise-1d66a04d
ent-dise-1d66a04d targeted_by h-16818f9bf1

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.